Is Ashwagandha Safe to Take Daily? How Long, When and How to Stop
In this article
- What happens if you take ashwagandha every day?
- How long can you stay on ashwagandha?
- How much ashwagandha a day did the trials use, and is 250 mg safe?
- Should you take ashwagandha in the morning or at night?
- Do you need to cycle ashwagandha or take breaks?
- What happens when you stop taking ashwagandha?
- Can you take it every day with magnesium, vitamin D, other supplements or medicines?
- What do UK and European regulators say about taking it daily?
- What we don't know
- Frequently asked questions
Ashwagandha root extract has been taken every day in placebo-controlled trials for 6 to 12 weeks, and in a few for up to 180 days: across 23 trials of a standardised root-only extract in 2,317 healthy adults at 125 to 600 mg a day, liver, kidney, blood, hormone and heart markers stayed within normal ranges.1 Nobody has studied years of use, no trial has compared daily use with cycling, and the published liver-injury cases, about 25 people in 13 reports to the end of 2025, typically began after weeks of use; a few months at a trial dose with a review point is what the evidence covers.2 Who must not take it is on who should not take ashwagandha; the benefits evidence is in the Wellgard ashwagandha guide.
Sources checked on 1 November 2026.
What happens if you take ashwagandha every day?
Over a typical 6 to 12 weeks, stress and anxiety scores fell more than placebo in a pooled analysis of 12 small trials, at low certainty, while a 12-week trial of 400 mg a day in overweight adults aged 40 to 75 found no difference from placebo on perceived stress.4, 5 In the most quoted trial, 64 stressed adults on 600 mg a day for 60 days saw cortisol fall about 28% against 8% on placebo: the one study, on a manufacturer-supplied extract, behind "lowers cortisol by 30%".6 Two unexpected changes: thyroxine rose by 0.61 µg/dL across 23 pooled trials with TSH unchanged, so anyone with a thyroid condition or on levothyroxine or liothyronine needs their prescriber's agreement, and fasting glucose fell by about 0.2 mmol/L at very low certainty, relevant only on glucose-lowering medicines.7, 8 Trial side effects were mild and infrequent: stomach upset, headache, drowsiness.1
How long can you stay on ashwagandha?
As long as the trials ran: 6 to 12 weeks in most, 180 days at the longest, and 80 healthy adults on 600 mg a day for 8 weeks showed no change in liver or thyroid tests.1, 9 The "not more than three months" rule misreads a US agency's note that ashwagandha may be safe in the short term, up to 3 months, with too little information to judge longer use: a description of the evidence, not a limit. Beyond six months the position is unstudied, so review at 8 to 12 weeks: has anything measurable changed? In the first case series, liver injury began 2 to 12 weeks in and liver tests normalised within 1 to 5 months of stopping; across the 25 published cases it was usually cholestatic or mixed, with jaundice and itching, and the three deaths were all in people with existing cirrhosis; dark urine, pale stools, itching, yellow skin or eyes, nausea or pain under the right ribs mean stop and see a GP that day.3, 2 Anyone with liver disease should not take it, and alcohol may add to the risk; the trials enrolled healthy adults, so they cannot exclude a rare reaction.2, 1
How much ashwagandha a day did the trials use, and is 250 mg safe?
240 to 600 mg a day of a standardised root extract, most often 300 mg twice daily or 240 to 250 mg once daily, for 6 to 12 weeks; the safety review covered 125 to 600 mg.10, 6, 1 The 240 mg once-daily trial ran 60 days in 60 stressed adults and found lower anxiety scores and morning cortisol than placebo, so 250 mg sits inside the studied band, with the same cautions.10 Above 600 mg a day the studies are few: a placebo-controlled pilot of 46 men at 675 mg, an open-label study stepping 18 volunteers up to 1,250 mg, and a 2026 single-arm study in which 145 healthy adults took 2,000 mg a day of root extract for 12 weeks, with liver, kidney and thyroid results inside the reference ranges and mild nausea the commonest complaint (5.5%); none compared a higher dose with 600 mg, so no upper amount has been set.15, 16, 19 Read extract milligrams, not the "equivalent to whole root" figure a 10:1 extract allows.
Should you take ashwagandha in the morning or at night?
No trial has compared morning with evening doses; twice-daily trials split the dose across the day. If it makes you drowsy, a side effect seen in the trials, take it in the evening; if a late dose leaves you wired, move it to the morning. "Sleepy or energised?" has both answers: in five pooled trials of 400 people, sleep improved more at 600 mg a day or more and after 8 weeks or more, and so did mental alertness on waking, while the 12-week trial with no stress difference found less fatigue.11, 5
Do you need to cycle ashwagandha or take breaks?
No trial has compared continuous with cycled use and every efficacy trial dosed continuously, so "five days on, two off" and "two weeks on, two off" are forum practice, not findings. A planned break after a review point tells you more than a ritual: stop, note what changes over two to four weeks, decide.
What happens when you stop taking ashwagandha?
For most people nothing noticeable: the trials ended without a taper and reported no withdrawal, though none looked for it. One published case describes it: a 20-year-old man who stopped 600 mg a day abruptly developed a racing heart, insomnia and anxiety shortly after stopping, with normal heart, liver and thyroid tests; the authors proposed a withdrawal effect and allowed that his underlying anxiety may have returned.12 Nothing has tested tapering, so stepping down over a week or two is sensible; tell your GP if your original symptoms return hard, and never stop a prescribed antidepressant or sleeping medicine at the same time. The trials measured anxiety scales, not emotional range; what to do about feeling flat is on what does ashwagandha do for the brain. A suspected reaction can be reported to your local authority's food safety team, which works with the Food Standards Agency.18
Can you take it every day with magnesium, vitamin D, other supplements or medicines?
Magnesium and vitamin D: no interaction has been reported in trials or case reports; magnesium's daily-use questions are on is it OK to take magnesium every day and its medicine spacing on what should you not take with magnesium. Lion's mane: no study of the pair; see ashwagandha vs lion's mane. Medicines belong to the safety page: thyroid hormones, sedatives, anti-seizure medicines, antidepressants, immunosuppressants, diabetes and blood-pressure medicines all warrant a pharmacist's advice first; in pregnancy, breastfeeding, under 18, with autoimmune disease or before surgery it is not taken at all.
What do UK and European regulators say about taking it daily?
Denmark's National Food Institute concluded in 2020 that no safe intake could be set for the root or its extracts, and it is prohibited in Danish supplements; the Dutch public-health institute advised against supplements and teas on 8 March 2024; the French food-safety agency advised on 19 April 2024 that pregnant or breastfeeding women, under-18s and people with thyroid, androgen, liver or heart disorders or on sedatives should not take it, without a ban; Germany's risk-assessment institute said on 10 September 2024 that children, pregnant and breastfeeding women and people with liver disease should not take it, calling the data insufficient. The UK Food Standards Agency ran a call for evidence from 8 July to 2 September 2024 and published its summary of the 19 responses on 25 June 2026. Ashwagandha has open safety questions that the UK Committee on Toxicity is assessing; its draft statement is not yet published.17, 13, 14 So on 1 November 2026 it is legal in UK supplements, assessment unfinished, and not "banned across Europe": Denmark alone prohibits it.
What we don't know
Whether years of daily use are safe: no placebo-controlled trial has run beyond 180 days.1 Whether cycling or breaks change anything: no trial has compared them with continuous use. Whether stopping causes withdrawal: the trials did not look for it, and the one published case could also be returning anxiety.12 And how often liver injury happens: 25 published cases cannot give a rate.2
Frequently asked questions
Why can't you take ashwagandha every day?
You can, within the trial pattern: a standardised root extract at 240 to 600 mg a day for a few months with a review point.1 The "can't" belongs to the groups on the safety page: pregnancy and breastfeeding, under-18s, liver disease or heavy drinking, thyroid conditions or medicine, immunosuppressants, sedatives, autoimmune disease and surgery.
Is it good to take ashwagandha before bed?
The sleep trials, compared in the Wellgard sleep guide, mostly gave 600 mg a day, and none compared a bedtime dose with a daytime one.11 If it makes you drowsy, the evening dose is the one to keep; if it keeps you awake, it is not.
What should ashwagandha be taken with?
Water or food; no trial has tested what it is best taken with. Keep alcohol away from it: a 2026 review of the liver cases says alcohol may add to the risk, though the reports are too few to show how.2
Is it safe to take ashwagandha pills every day?
Capsules, gummies and powders differ in what a serving delivers, not in kind: for capsules and powders, read the extract milligrams and set them against the 240 to 600 mg trial band; gummies state their serving on the pack; the same review point and cautions apply to all three; in a sleep blend, how to choose a melatonin-free sleep supplement reads the other lines.
Sources
- Coope OC, et al. Back to the roots: safety and tolerability of standardised ashwagandha (Withania somnifera) root extract in healthy adults, a systematic review of biomarkers and adverse events. Pharmaceuticals, 2026. Systematic review, 23 randomised trials, 2,317 healthy adults; no external funding, two authors employed by UK supplement companies. PubMed 42198398.
- McIntyre D, et al. Ashwagandha (Withania somnifera)-associated liver injury: a scoping review of clinical characteristics and safety considerations. Cureus, 2026. Scoping review, 13 case publications, 25 patients; no funding received. PubMed 42367407.
- Björnsson HK, et al. Ashwagandha-induced liver injury: a case series from Iceland and the US Drug-Induced Liver Injury Network. Liver International, 2020. Case series, 5 patients; US National Institutes of Health funding. PubMed 31991029.
- Akhgarjand C, et al. Does ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. Phytotherapy Research, 2022. Systematic review and meta-analysis, 12 randomised trials, 1,002 adults, low certainty; funder not stated in the abstract. PubMed 36017529.
- Smith SJ, Lopresti AL, Fairchild TJ. Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial. Journal of Psychopharmacology, 2023. Randomised placebo-controlled trial, 120 adults aged 40 to 75, 12 weeks; funded by the extract's maker. PubMed 37740662.
- Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 2012. Randomised placebo-controlled trial, 64 adults with chronic stress, 60 days; extract supplied by its maker, no other support declared. PubMed 23439798.
- Fornalik M, et al. Hormonal modulation with Withania somnifera: systematic review and meta-analysis of randomized-controlled trials. Planta Medica, 2026. Systematic review and meta-analysis, 23 randomised trials, 1,706 adults; no conflicts declared, funder not stated. PubMed 41740946.
- Farrin N, et al. The effects of ashwagandha (Withania somnifera) supplementation on fasting blood glucose and HbA1c: a systematic review and dose-response meta-analysis of randomized controlled trials. Diabetes Research and Clinical Practice, 2026. Systematic review and meta-analysis, 11 randomised trials, 667 people, very low certainty; no competing interests declared. PubMed 42641800.
- Verma N, et al. Safety of ashwagandha root extract: a randomized, placebo-controlled study in healthy volunteers. Complementary Therapies in Medicine, 2021. Randomised placebo-controlled trial, 80 healthy adults, 8 weeks; funder not stated in the abstract. PubMed 33338583.
- Lopresti AL, et al. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: a randomized, double-blind, placebo-controlled study. Medicine, 2019. Randomised placebo-controlled trial, 60 stressed adults, 60 days; funded by the extract's maker. PubMed 31517876.
- Cheah KL, et al. Effect of ashwagandha (Withania somnifera) extract on sleep: a systematic review and meta-analysis. PLoS One, 2021. Systematic review and meta-analysis, 5 randomised trials, 400 adults; no competing interests declared. PubMed 34559859.
- Holzman A, et al. Unmasking potential withdrawal effects of ashwagandha: a case report and review. Cureus, 2025. Case report, 1 man; no funding received. PubMed 40476122.
- Food Standards Agency. Summary of responses to call for evidence on ashwagandha, 25 June 2026; 19 responses. gov.uk.
- Committee on Toxicity. 8th September 2026 meeting: third draft statement on ashwagandha discussed; paper TOX/2026/30 not yet available on 1 November 2026. gov.uk.
- Ambiye VR, et al. Evid Based Complement Alternat Med, 2013. Randomised placebo-controlled pilot trial, 46 men with low sperm counts, 90 days; funder not stated, no conflicts declared. PubMed 24371462.
- Raut AA, et al. J Ayurveda Integr Med, 2012. Open-label dose-escalation study, 18 healthy volunteers, 30 days; Indian Council of Medical Research funding. PubMed 23125505.
- ANSES (French food-safety agency). Opinion 2021-SA-0077 on the risks of Withania somnifera preparations in food supplements, 19 April 2024, including the Danish (2020) and Dutch (2024) assessments. Expert committee opinion. anses.fr.
- Food Standards Agency. How to report a food safety or hygiene issue for members of the public. Updated 5 August 2026. gov.uk.
- Movva N, et al. Safety and tolerability of Ashwagandha (Withania somnifera) root extract in healthy adults: a prospective, non-comparative study. Frontiers in Nutrition, 2026. Single-arm study with no placebo group, 145 healthy adults (124 completed), 12 weeks; funded by the extract's manufacturer, with the capsules supplied by the company that markets it; no conflict declared. PubMed 42253745.
Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.